Clariant rejects $1 billion OMV claim alleging competition law infringement
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 27 2025
0mins
Should l Buy CE?
Source: Reuters
Clariant's Legal Challenge: Clariant is facing a €1 billion damages claim from OMV for alleged competition law violations in the ethylene purchasing market, which Clariant firmly rejects and plans to defend against.
Previous Claims and Fines: This is not the first time Clariant has faced such claims; it previously received similar allegations from BASF and TotalEnergies, and was fined by the European Commission in 2020 for collusion related to ethylene prices.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CE
Wall Street analysts forecast CE stock price to fall
10 Analyst Rating
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 56.800
Low
43.00
Averages
54.78
High
75.00
Current: 56.800
Low
43.00
Averages
54.78
High
75.00
About CE
Celanese Corporation is a chemical and specialty materials company which is engaged in producing engineered polymers that are used in applications, as well as acetyl products, which are intermediate chemicals for all industries. The Company operates through two segments, which include Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces and supplies a portfolio of specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Its Engineered Materials are used in a range of end-use products including fuel system components, automotive safety systems, medical applications, consumer electronics, appliances, industrial products, and others. The Acetyl Chain segment includes the integrated chain of acetic acid, vinyl acetate monomer (VAM), acetic anhydride, acetate esters, emulsion polymers, ethylene vinyl acetate (EVA) polymers, redispersible powders (RDP), and acetate tow businesses.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Rating Upgrade: J.P. Morgan upgraded Celanese from Neutral to Overweight with a price target of $68, reflecting confidence in the company's future growth despite a 14% drop in shares last week due to disappointing free cash flow growth expectations.
- Earnings Growth Outlook: Analysts expect Celanese to experience sharp earnings growth in 2026 driven by price inflation in acetic acid derivatives like VAM and VAE, alongside anticipated persistent shortages in the acetyl chain, which could keep average acetyl chemicals prices elevated in the near term.
- Raw Material Price Impact: The closure of the Strait of Hormuz is expected to dislocate raw material values, leading to higher average prices for acetic acid and vinyl acetate monomer, positively impacting Celanese's profitability according to analysts.
- Cash Flow Expectations: J.P. Morgan anticipates that Celanese will generate free cash flow equivalent to 11%-13% of its share price in 2026-2027, further bolstering investor confidence in the company's future financial health.
See More
- Goldman Sachs Bullish on Aevex: Goldman Sachs initiates coverage of Aevex (AVEX) with a Buy rating and a $34 price target, based on a 5.4X CY27 EV/Sales, indicating confidence in the company's unique position in the drone market and its growth potential.
- Citi Raises Broadcom Target: Citi raises Broadcom's price target from $475 to $500, applying a 20x multiple to FY28 EPS of $25, reflecting optimism about the company's earnings visibility and maintaining its status as the #1 semiconductor pick for 2026.
- JPMorgan Upgrades Braskem: JPMorgan upgrades Braskem to Overweight from Neutral, citing improved market fundamentals, tighter supply, and strengthened governance post-restructuring, which are expected to enhance profit margins in the chemical sector.
- Evercore Initiates Benitec Coverage: Evercore initiates coverage of Benitec Biopharma with an Overweight rating, highlighting significant upside potential in the rare disease market, suggesting promising investment opportunities ahead.
See More
- Cash Generation Focus: CEO Scott Richardson emphasized that Celanese will continue to prioritize cash generation despite low end-use demand, with expectations to leverage supply chain disruptions for performance improvement in Q2.
- Absorption Cost Impact: CFO Chuck Kyrish projected an additional $50 million absorption cost in the Engineered Materials segment for Q2, which will negatively impact the income statement, while the company is reducing complexity to optimize inventory.
- EPS Guidance: Management confirmed a target of $3 per share in EPS for the second half, assuming supply chains normalize by the end of Q2, although high feedstock costs may negatively affect demand.
- Cautious M&A Strategy: Kyrish indicated that the company will aggressively pursue divestitures but has not included any cash proceeds in its planning due to market uncertainties, reflecting a cautious approach to future transactions.
See More
- Strong Financial Performance: Celanese reported net sales of $2.3 billion for Q1 2026, reflecting a 6% sequential increase driven by a 5% rise in volume, indicating robust demand and stable pricing strategies in the market.
- Improved Profitability: The adjusted earnings per share for the first quarter reached $0.85, a 57% increase year-over-year, showcasing the company's enhanced cost productivity and favorable product mix in its Engineered Materials and Acetyl Chain segments.
- Strategic Adjustments: The company announced the closure of its nylon 6,6 polymerization unit in Singapore to reposition its nylon business for greater competitiveness, while successfully restarting the VAM unit in Frankfurt, Germany, enhancing supply reliability and demonstrating agility in responding to market changes.
- Optimistic Cash Flow Outlook: Celanese raised its full-year free cash flow outlook to $700 to $800 million for 2026, reflecting confidence in accelerating deleveraging and driving revenue growth, which is expected to further strengthen its financial stability.
See More
- Earnings Report Announcement: Celanese Corp is set to report its Q1 earnings on May 5, with analysts expecting earnings of $0.88 per share, reflecting market confidence in the company's profitability and potentially positive stock price implications.
- Dividend Declaration: The company has declared a dividend of $0.03 per share, which, while relatively modest, demonstrates its commitment to shareholder returns and may attract income-seeking investors looking for stability.
- Stock Performance: Celanese shares closed at $68.74 on Monday, providing a benchmark for the company's upcoming earnings report, as investors will closely monitor the results to assess potential stock price volatility.
- Market Expectations: Analysts maintain an optimistic outlook for the upcoming earnings report, suggesting that if actual earnings exceed expectations, it could drive the stock price higher, whereas disappointing results may lead to declines, highlighting the market's keen interest in the company's financial health.
See More
- Reason for Price Increase: Celanese announced a price increase for various engineered materials effective May 1, 2026, due to market changes and global supply chain disruptions, demonstrating the company's responsiveness to dynamic market conditions.
- Specific Increases: The price hikes vary by material, with non-flame retardant PA6 products increasing by $0.30/kg in Asia and PA66 products by $0.50/kg, reflecting the company's strategic pricing approach across different markets.
- Market Positioning: Despite challenges, Celanese remains well-positioned to support its customers through its regional supply chain and manufacturing sites, along with its technology and innovation centers, enhancing its competitive edge in the market.
- Company Overview: Celanese is a global leader in chemistry with net sales of $9.5 billion in 2025 and over 11,000 employees, committed to sustainability and social responsibility, showcasing its significant industry impact.
See More









